³í¹®) Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer
¿¬¼¼¾Ïº´¿ø Á¾¾ç³»°ú ¶ó¼±¿µ, Á¤¹Î±Ô, ÀÌÃæ±Ù, ±èâ°ï ±³¼ö ¿¬±¸ÆÀ